4.4 Editorial Material

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma

Journal

LANCET HAEMATOLOGY
Volume 8, Issue 6, Pages E389-E392

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S2352-3026(21)00110-1

Keywords

-

Categories

Funding

  1. Roche
  2. Janssen
  3. Gilead
  4. Bayer
  5. Astra Zeneca
  6. Verastem
  7. AGIOS
  8. AQUINOX
  9. Morphosys

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available